Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NNOX
NNOX logo

NNOX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.660
Open
2.600
VWAP
2.56
Vol
614.53K
Mkt Cap
165.09M
Low
2.485
Amount
1.57M
EV/EBITDA(TTM)
--
Total Shares
65.38M
EV
136.58M
EV/OCF(TTM)
--
P/S(TTM)
13.23
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
Show More

Events Timeline

(ET)
2026-03-13
17:30:00
Nano-X Imaging Files $100M Mixed Securities Shelf
select
2026-03-03 (ET)
2026-03-03
08:10:00
Nano-X Imaging Signs Distribution Agreement with Imperial Imaging Technology
select
2026-02-17 (ET)
2026-02-17
08:30:00
Nano-X Imaging to Showcase Nanox.ARC System Live in Europe for the First Time
select
2026-02-03 (ET)
2026-02-03
08:40:00
Nano-X Imaging Receives FDA Clearance for TAP2D Image Enhancement
select
2026-01-14 (ET)
2026-01-14
08:50:00
Nanox Imaging Partners with Adriamed for Nanox.ARC System
select
2025-11-25 (ET)
2025-11-25
08:11:34
Nano-X Imaging partners with Althea France SARL for distribution collaboration
select
2025-11-24 (ET)
2025-11-24
08:33:10
NICE Recommends Nano-X.AI Bone Solutions for Early Value Assessment
select
2025-11-20 (ET)
2025-11-20
08:04:27
Nano-X Imaging anticipates deploying more than 100 units by the end of the year.
select
2025-11-20
08:03:00
Nano-X Imaging announces Q3 earnings per share of 15 cents, unchanged from last year.
select
2025-11-18 (ET)
2025-11-18
09:31:39
Nano-X Forms Strategic Alliance with 3DR Labs
select

News

seekingalpha
8.5
02-03seekingalpha
Nano-X Imaging Receives FDA Approval for New Functionality
  • FDA Approval: Nano-X Imaging's digital X-ray systems, Nanox.ARC and Nanox.ARC X, received FDA clearance for a new cloud-enabled image enhancement feature, positioning them as leading diagnostic solutions in the industry and likely boosting market share.
  • Image Enhancement Capability: The new TAP2D feature allows radiologists to generate 2D images directly from tomosynthesis scans, simplifying clinical workflows and enhancing operational efficiency, which is expected to improve customer satisfaction and usage frequency.
  • Standalone Imaging Solution: CEO Erez Meltzer noted that this functionality will enable Nanox.ARC to serve as a standalone primary imaging solution, similar to its CE Mark certification in Europe, further expanding its market application scope.
  • Commercial Rollout Plans: Nano-X plans to launch the enhancement software as part of its ongoing commercial rollouts of imaging improvements, which is expected to generate new revenue streams and enhance its competitiveness in the medical imaging market.
Newsfilter
8.5
02-03Newsfilter
Nanox Receives FDA Clearance for New Imaging Technology
  • FDA Clearance Achieved: Nanox announced that its TAP2D image enhancement capability has received FDA 510(k) clearance, enabling radiologists to generate clear 2D images from digital tomosynthesis scans, enhancing diagnostic efficiency while reducing patient radiation exposure.
  • Innovation Driving Efficiency: This new feature not only supports the generation of both 3D and 2D views but also delivers additional views automatically within the existing clinical environment, thereby streamlining workflows and improving the quality of medical services.
  • Strategic Market Positioning: This clearance marks a significant advancement in Nanox's strategy to position its tomosynthesis systems as primary diagnostic solutions in the U.S. market, which is expected to further enhance its influence in the global medical imaging sector.
  • Ongoing Technology Upgrades: Nanox plans to roll out the TAP2D software to existing installations, demonstrating the company's commitment to continuous technological innovation aimed at improving patient care quality and accessibility to medical services.
PRnewswire
8.5
01-27PRnewswire
Rapid Growth in Cardiac AI Diagnostics Market
  • Market Surge: The global medical imaging market reached $45.5 billion in 2026, indicating a significant shift towards AI-native precision, particularly due to the rising demand for heart monitoring in cancer treatments.
  • Rise of Cardiac AI Diagnostics: The cardiac AI diagnostics sector hit $2.22 billion in 2026, driven by the urgent need for continuous imaging to monitor heart dysfunction, enhancing the company's competitive edge in the medical technology market.
  • Strategic Partnership Enhances Value: Ventripoint's collaboration with Summit Sciences to develop ROI models illustrates how hospitals can achieve cost savings through technological improvements, further solidifying its market position in cardiac care.
  • Executive Appointment Fuels Growth: The appointment of David Swetlow as CFO, with extensive experience in medical technology, is expected to accelerate market adoption and revenue growth, driving the execution of the company's commercial strategy.
Newsfilter
8.5
01-27Newsfilter
Rapid Growth in Cardiac AI Diagnostics Market
  • Market Size Surge: The global medical imaging market reached $45.5 billion in 2026, indicating a significant shift towards AI-driven precision, with the cardiac AI diagnostics sector hitting $2.22 billion, reflecting a critical demand for continuous imaging.
  • Technological Innovation: VentriPoint Diagnostics is transforming standard 2D ultrasound images into MRI-level 3D heart models, significantly reducing costs and complexity, which is expected to drive rapid growth in its subscription business.
  • Surge in Investment Demand: The company recently doubled its private placement from $500,000 to $1 million, with funds allocated for commercialization and market expansion, showcasing strong investor confidence in its technology and market potential.
  • Strategic Partnership: VentriPoint's collaboration with Summit Sciences to develop ROI models aims to demonstrate the economic value of its technology to hospitals, further solidifying its market position in medical imaging.
Newsfilter
7.5
01-14Newsfilter
Nanox Partners with Adriamed to Expand European Market Presence
  • Market Expansion Partnership: Nanox has formed an exclusive partnership with Serbian medical device distributor Adriamed to introduce its Nanox.ARC digital imaging system to the Western Balkans, which is expected to significantly enhance accessibility and quality of medical imaging in the region.
  • Technological Advantage: The Nanox.ARC system utilizes advanced 3D imaging technology to provide enhanced diagnostic capabilities at a lower cost than traditional systems, which is anticipated to improve patient care and long-term health outcomes, aligning with Nanox's strategic goals.
  • Regional Leadership: This collaboration will further solidify Nanox's leadership position in markets such as Serbia, Montenegro, and Bosnia and Herzegovina, driving commercial growth across Europe.
  • Long-term Value Creation: The combination of Adriamed's market penetration capabilities and Nanox's innovative technology aims to create long-term value for healthcare providers, supporting broader access to medical imaging, particularly in underserved communities.
NASDAQ.COM
3.5
2025-12-11NASDAQ.COM
Tempus AI's Strategic Initiative to Broaden Its Focus Beyond Cancer Care
  • Tempus AI Developments: Tempus AI is advancing its diagnostic software across various medical fields and has partnered with Northwestern University to enhance Alzheimer’s research using its AI analytics platform, Lens. The company also received FDA clearances for its AI-powered cardiac imaging tools.

  • Strategic Acquisitions: Tempus has strengthened its capabilities through acquisitions, including Arterys for imaging data analysis and Paige for digital pathology, significantly expanding its proprietary datasets and analytical tools.

  • GE HealthCare Innovations: GE HealthCare launched the Voluson Performance series for women's health and plans to acquire icometrix to integrate AI-driven brain imaging analysis into its MRI systems, enhancing workflow efficiency.

  • Market Performance and Future Outlook: Tempus shares have surged 74% over the past year, contrasting with industry declines, while the article discusses the potential for significant wealth creation in the next wave of AI investments, highlighting emerging companies poised for growth.

Wall Street analysts forecast NNOX stock price to rise
2 Analyst Rating
Wall Street analysts forecast NNOX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
7.00
Averages
7.00
High
7.00
Current: 0.000
sliders
Low
7.00
Averages
7.00
High
7.00
Alliance Global Partners
Buy
downgrade
$9 -> $7
AI Analysis
2025-05-22
Reason
Alliance Global Partners
Price Target
$9 -> $7
AI Analysis
2025-05-22
downgrade
Buy
Reason
Alliance Global Partners lowered the firm's price target on Nano-X Imaging to $7 from $9 and keeps a Buy rating on the shares. The firm cites the company's Q1 revenue missing forecasts, suggesting a challenging macro environment, the analyst tells investors in a research note.
D. Boral Capital
Jason Kolbert
Strong Buy
Maintains
$15
2025-04-17
Reason
D. Boral Capital
Jason Kolbert
Price Target
$15
2025-04-17
Maintains
Strong Buy
Reason

Valuation Metrics

The current forward P/E ratio for Nano-X Imaging Ltd (NNOX.O) is -4.05, compared to its 5-year average forward P/E of -10.71. For a more detailed relative valuation and DCF analysis to assess Nano-X Imaging Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-10.71
Current PE
-4.05
Overvalued PE
-4.01
Undervalued PE
-17.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.09
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.44
Undervalued EV/EBITDA
-11.62

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
434.33
Current PS
8.45
Overvalued PS
1701.32
Undervalued PS
-832.66

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

create swing trade setup
Intellectia · 358 candidates
Price: $1.00 - $5.00List Exchange: XNAS, XNYS, XASEMoving Average Relationship: PriceAboveMA20, PriceBelowMA5, PriceBelowMA10Week Price Change Pct: $-10.00 - $10.00Macd: bullish, positive
Ticker
Name
Market Cap$
top bottom
TCRT logo
TCRT
Alaunos Therapeutics Inc
7.60M
OSTX logo
OSTX
OS Therapies Inc
53.17M
NNOX logo
NNOX
Nano-X Imaging Ltd
169.34M
FLNT logo
FLNT
Fluent Inc
107.58M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
685.30M
MRT logo
MRT
Marti Technologies Inc
175.91M
Give me something more volatile
Intellectia · 18 candidates
Market Cap: 30.00M - 1000.00MPrice: $0.50 - $25.00Price Change Pct: >= $5.00Beta: HighRiskWeek Price Change Pct: >= $3.00
Ticker
Name
Market Cap$
top bottom
PSFE logo
PSFE
Paysafe Ltd
428.67M
KZIA logo
KZIA
Kazia Therapeutics Ltd
113.47M
ACVA logo
ACVA
ACV Auctions Inc
964.36M
SABR logo
SABR
Sabre Corp
711.30M
LAW logo
LAW
CS Disco Inc
248.88M
AENT logo
AENT
Alliance Entertainment Holding Corp
316.45M
what stock under $5 should I buy today?
Intellectia · 56 candidates
Market Cap: >= 100.00MRegion: USPrice: $0.50 - $5.00Quarter Revenue Yoy Growth: >= 5.0%List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
API logo
API
Agora Inc
431.16M
IOVA logo
IOVA
Iovance Biotherapeutics Inc
1.58B
GOGO logo
GOGO
Gogo Inc
599.67M
IMPP logo
IMPP
Imperial Petroleum Inc
188.03M
OCGN logo
OCGN
Ocugen Inc
608.82M
TRON logo
TRON
TRON Inc
359.44M
list top top 20 ai companies
Intellectia · 18 candidates
Themes: AI Beneficiary
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B
good penny stocks to invest in
Intellectia · 32 candidates
Market Cap: <= 500.00MPrice: <= $5.00Quarter Revenue Yoy Growth: >= 10.0%Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAN logo
CAN
Canaan Inc
498.64M
ORGO logo
ORGO
Organogenesis Holdings Inc
487.34M
CERS logo
CERS
Cerus Corp
485.98M
OCGN logo
OCGN
Ocugen Inc
465.36M
API logo
API
Agora Inc
402.42M
NNDM logo
NNDM
Nano Dimension Ltd
395.43M
ai companies
Intellectia · 18 candidates
Themes: AI BeneficiaryWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B
what AI company's have equity divedends
Intellectia · 14 candidates
Dividend Yield Ttm: >= 0Themes: AI BeneficiaryIs Optionable: True
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B

Whales Holding NNOX

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nano-X Imaging Ltd (NNOX) stock price today?

The current price of NNOX is 2.525 USD — it has decreased -2.13

What is Nano-X Imaging Ltd (NNOX)'s business?

Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.

What is the price predicton of NNOX Stock?

Wall Street analysts forecast NNOX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NNOX is7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nano-X Imaging Ltd (NNOX)'s revenue for the last quarter?

Nano-X Imaging Ltd revenue for the last quarter amounts to 3.45M USD, increased 13.72

What is Nano-X Imaging Ltd (NNOX)'s earnings per share (EPS) for the last quarter?

Nano-X Imaging Ltd. EPS for the last quarter amounts to -0.21 USD, decreased -8.70

How many employees does Nano-X Imaging Ltd (NNOX). have?

Nano-X Imaging Ltd (NNOX) has 165 emplpoyees as of March 14 2026.

What is Nano-X Imaging Ltd (NNOX) market cap?

Today NNOX has the market capitalization of 165.09M USD.